 |
| Bone morphogenetic protein 2 |
published studies of Medtronic's bone morphogenetic protein-2 product known as Infuse, a unprecedented publishing event that was prompted in part by a Milwaukee Journal Sentinel/Medpage Today investigation. MedPageToday
Saturday, July 2, 2011
Spine Journal Takes Aim at Infuse Research
The Spine Journal is devoting an entire issue to critical reviews of
published studies of Medtronic's bone morphogenetic protein-2 product known as Infuse, a unprecedented publishing event that was prompted in part by a Milwaukee Journal Sentinel/Medpage Today investigation. MedPageToday
published studies of Medtronic's bone morphogenetic protein-2 product known as Infuse, a unprecedented publishing event that was prompted in part by a Milwaukee Journal Sentinel/Medpage Today investigation. MedPageToday
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment